NASDAQ:AGMB

Agomab Therapeutics N.v. American Depositary Shares Stock Forecast

etoro logo Buy AGMB
*Your capital is at risk
$15.00
+0.500 (+3.45%)
At Close: Aug 10, 2026

Should you buy AGMB stock?

Last updated:

Based on market data through , StockInvest.us rates Agomab Therapeutics N.v. American Depositary Shares (AGMB) as a Buy Candidate with a technical score of 4.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 15.65%
  • 3-month trend forecast Up 18.51%
  • Buy Candidate 4.42
AI Analysis AI Analysis of AGMB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AGMB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Agomab Therapeutics N.v. American stock price on Monday moving 13.22% between high and low
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jul 23, 2026 Gain 15.65%

The Agomab Therapeutics N.v. American stock price gained 3.45% on the last trading day (Monday, 10th Aug 2026), rising from $14.50 to $15.00. During the last trading day the stock fluctuated 13.22% from a day low at $13.64 to a day high of $15.44. The price has risen in 7 of the last 10 days and is up by 19.9% over the past 2 weeks. Volume fell on the last day by -280 thousand shares and in total, 87 thousand shares were bought and sold for approximately $1.31 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 18.51% during the next 3 months and, with a 90% probability hold a price between $13.63 and $22.78 at the end of this 3-month period.

AGMB Signals & Forecast

The Agomab Therapeutics N.v. American stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.06 and $13.01. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -15.82%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Agomab Therapeutics N.v. American stock

Agomab Therapeutics N.v. American finds support from accumulated volume at $14.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $1.80 between high and low, or 13.22%. For the last week the stock has had daily average volatility of 9.30%.

Our recommended stop-loss: $14.25 (-5.02%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 29 days ago.)

Trading Expectations (AGMB) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Agomab Therapeutics N.v. American Depositary Shares to open at $14.69, and during the day (based on 14 day Average True Range), to move between $14.42 and $15.58, which gives a possible trading interval of +/-$1.16 (+/-8.06%) up or down from last closing price. If Agomab Therapeutics N.v. American Depositary Shares takes out the full calculated possible swing range there will be an estimated 8.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.50 (3.33%) than the resistance at $17.82 (18.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Agomab Therapeutics N.v. American Depositary Shares stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agomab Therapeutics N.v. American stock to perform well in the short-term.

Current score: 4.423 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $14.69 ( 2.04%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AGMB Performance

Trading levels for AGMB

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.50 9.99%
R2 15.81 5.40%
R1 15.38 2.56%
Price 15.00
S1 14.01 -6.63%
S2 13.58 -9.47%
S3 12.89 -14.06%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 17.82 18.80%
Price 15.00
S1 14.50 -3.33%
S2 13.52 -9.87%
S3 12.98 -13.47%

FAQ

What is the symbol for Agomab Therapeutics N.v. American Depositary Shares Stock and on which exchange is it traded?
The symbol for Agomab Therapeutics N.v. American Depositary Shares is AGMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agomab Therapeutics N.v. American Depositary Shares Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Agomab Therapeutics N.v. American Depositary Shares (AGMB) as a Buy Candidate with a technical score of 4.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jul 23, 2026, the price has risen 15.65%. The current 3-month trend forecast projects a rise of 18.51%.

How to buy Agomab Therapeutics N.v. American Depositary Shares Stock?
Agomab Therapeutics N.v. American Depositary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agomab Therapeutics N.v. American Depositary Shares Stock.

What's the current price of Agomab Therapeutics N.v. American Depositary Shares Stock?
As of the end of day on the Aug 10, 2026, the price of an Agomab Therapeutics N.v. American Depositary Shares (AGMB) share was $15.00.

What is the 52-week high and low for Agomab Therapeutics N.v. American Depositary Shares Stock?
The 52-week high for Agomab Therapeutics N.v. American Depositary Shares Stock is $17.82 and the 52-week low is $8.75.

What is the market capitalization of Agomab Therapeutics N.v. American Depositary Shares Stock?
As of the Aug 10, 2026, the market capitalization of Agomab Therapeutics N.v. American Depositary Shares is 738.72M.

When is the next earnings date for Agomab Therapeutics N.v. American Depositary Shares?
The upcoming earnings date for Agomab Therapeutics N.v. American Depositary Shares is Sep 02, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE